Venus Remedies Limited Enoxaparin Export Data — India (DGFT 2022–2026)

Name: Venus Remedies Limited Enoxaparin Export Records India — #4 Exporter, 182 Shipments, $5.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Enoxaparin

India Pharmaceutical Trade Intelligence

$209.4M223 Suppliers118 CountriesHS 30049099

ExportsIndia → UNITED STATES49.0%India → SAUDI ARABIA22.0%

ImportsFRANCE → India$2.7B CHINA → India$3.2M

#1 Supplier: GLAND PHARMA #1 Buyer: FRESENIUS KABI

Venus Remedies Limited — Enoxaparin Exporter #4 | $5.1M Trade Value | TransData Nexus | TransData Nexus

Venus Remedies Limited — Enoxaparin Exporter Profile

Indian Pharmaceutical Exporter · #4 for Enoxaparin · $5.1M export value · DGFT Verified

Venus Remedies Limited is the #4 Indian exporter of Enoxaparin with $5.1M in export value and 182 verified shipments. Venus Remedies Limited holds a 2.4% market share in Enoxaparin exports across 22 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.

Venus Remedies Limited — Enoxaparin Export Profile: Buyers & Destinations

Venus Remedies Limited Enoxaparin export treemap — buyers and destination countries | TransData Nexus

Where Does Venus Remedies Limited Export Enoxaparin?

Country	Value	Shipments	Share
PHILIPPINES	$462.5K	18	13.8%
LEBANON	$412.7K	13	12.3%
SAUDI ARABIA	$345.7K	28	10.3%
UNITED ARAB EMIRATES	$332.4K	9	9.9%
OMAN	$295.3K	21

Who Are the Top Buyers of Enoxaparin from Venus Remedies Limited?

Buyer	Country	Value	Orders
S T C	SAUDI ARABIA	$345.7K	20
MASSOUD PHARMA COMPANY LIMITED	LEBANON	$300.0K	6
PT M L	INDONESIA	$196.6K	6
2MG 2MG INC	PHILIPPINES	$196.4K	7
T P D S L	UNITED ARAB EMIRATES	$173.1K	5
LINDMED TRADE S.L	SPAIN	$150.0K	3
L Z C A	VENEZUELA	$140.1K	3
W M T L	GEORGIA	$136.8K	5
IBN SINA PHARMACY LLC,	OMAN	$130.1K	4
H P P L	NAMIBIA	$107.1K	3

Venus Remedies Limited supplies Enoxaparin to 44 buyers globally. The largest buyer is S T C (SAUDI ARABIA), followed by MASSOUD PHARMA COMPANY LIMITED (LEBANON) and PT M L (INDONESIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Enoxaparin Formulations Does Venus Remedies Limited Export?

Product Description / Formulation	Value	Shipments
ENOXAPARIN SODIUM INJECTION BP (40MG/0.4ML)PARIN E 40 MG BN.X4CA042A,X4CA052A,MD.03/2024,ED.02/2026	$134.6K	3
PARIN E 40 MG ENOXAPARIN SODIUM INJECTION BP 40 MG/0.4 ML EACH PRE-FIILED SYRINGE CONTAINS: ENOXAPARIN SODIUM BP .. ..	$107.1K	3
ENOXAPARIN SODIUM INJECTION BP 60MG/0.6M	$100.0K	2
PARIN-E 60MG ENOXAPARIN SODIUM INJ BP 60	$100.0K	2
ENOXAPARIN SODIUM INJECTION BP(40MG/0.4M	$83.3K	3
ENOXAPARIN SODIUM INJECTION BP (60MG/0.6ML)COGUPERIN 60 MG	$82.5K	3
ENOXAPARIN SODIUM INJECTION BP(60MG/0.6ML)COGUPERIN 60MG,M/D.X4BA073A,X4BA083A,X4CA113B,M/T.02/24,03/24,E/DT.01/27,02/27	$82.1K	3
ENOXAPARIN SODIUM INJECTION BP(80MG/0.8ML)COGUPERIN 80MG,B/N.X4BA094A,X4BA104A,X4BA104C,M/D.02/24,,E/DT.01/27	$76.9K	3
ENOXAPARIN SODIUM INJECTION BP (40MG/0.4	$59.9K	2
ENOXAPARIN SODIUM INJECTION BP (40MG/0.4ML)COGUPERIN 40 MG	$58.7K	3

Venus Remedies Limited exports 158 distinct Enoxaparin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ENOXAPARIN SODIUM INJECTION BP (40MG/0.4ML)PARIN E 40 MG BN with 3 shipments worth $134.6K.

How Does Venus Remedies Limited Compare to Nearest Enoxaparin Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	GLAND PHARMA LIMITED	$24.8M	495	25	$50.0K
3	BIOLOGICAL E. LIMITED	$11.3M	226	5	$50.0K
4	VENUS REMEDIES LIMITED ★	$5.1M	182	22	$27.8K
6	EMCURE PHARMACEUTICALS LIMITED	$4.1M	187	16	$21.8K
5	BRAWN LABORATORIES LIMITED	$3.6M	72	7	$50.0K

Venus Remedies Limited ranks #4 among 223 Indian Enoxaparin exporters. Average shipment value of $27.8K compared to the market average of $397.9K. The closest competitors by value are GLAND PHARMA LIMITED and BIOLOGICAL E. LIMITED.

Which Indian Ports Ship Enoxaparin Exports?

Port	Shipments	% Share
HYDERABAD ICD	555	16.8%
HYDERABAD ICD (INSNF6)	455	13.8%
SAHAR AIR CARGO ACC (INBOM4)	276	8.3%
SAHAR AIR	251	7.6%
DELHI AIR CARGO ACC (INDEL4)	165	5.0%
DELHI AIR	159	4.8%
NHAVA SHEVA SEA (INNSA1)	150	4.5%
HYDERABAD AIR	120	3.6%

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Enoxaparin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)

Venus Remedies Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)

These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Enoxaparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 187 individual customs records matching Venus Remedies Limited exporting Enoxaparin, covering 158 formulations to 22 countries via 44 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 118+ countries, 505+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Enoxaparin

Enoxaparin

Venus Remedies Limited — Enoxaparin Exporter Profile

Venus Remedies Limited — Enoxaparin Export Profile: Buyers & Destinations

Where Does Venus Remedies Limited Export Enoxaparin?

Who Are the Top Buyers of Enoxaparin from Venus Remedies Limited?

What Is India's Total Enoxaparin Export Value and How Much Does Venus Remedies Limited Contribute?

What Is the Average Shipment Value for Venus Remedies Limited's Enoxaparin Exports?

How Does Venus Remedies Limited Compare to Other Indian Enoxaparin Exporters?

What Enoxaparin Formulations Does Venus Remedies Limited Export?

How Does Venus Remedies Limited Compare to Nearest Enoxaparin Exporters?

Which Indian Ports Ship Enoxaparin Exports?

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Enoxaparin Exports

Venus Remedies Limited — Regulatory Compliance & Quality Standards

About Venus Remedies Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Enoxaparin Export Data from Venus Remedies Limited

Enoxaparin Stats

Company Overview

Top Products by Venus Remedies Limited

Related Analysis

Need Detailed Export Data?

Data Source